Adopting the estimand framework in prophylactic vaccine trials.
Beckers F, Karkada N, Yang Y, Scott J, Huang L, Klinglmüller F, Fay MP, Englert S, Spiessens B, Van Dromme I, Shekar T, Zhou H, Deng Q, Casula D, Janes H, Moulton LH.
Beckers F, et al.
Vaccine. 2025 Oct 3;64:127645. doi: 10.1016/j.vaccine.2025.127645. Epub 2025 Sep 3.
Vaccine. 2025.
PMID: 40907068
Free article.
Review.
The estimand framework as outlined in ICH E9(R1) has been extensively discussed and implemented in clinical trials of therapeutic products. ...Finally, we provide considerations and examples for summarizing study estimands and data handling which may be incorporated …
The estimand framework as outlined in ICH E9(R1) has been extensively discussed and implemented in clinical trials of therapeutic pro …